---
figid: PMC9655342__cancers-14-05431-g003
figtitle: Targeted Therapies in Advanced and Metastatic Urothelial Carcinoma
organisms:
- Homo sapiens
- NA
organisms_ner:
- Homo sapiens
- Danio rerio
pmcid: PMC9655342
filename: cancers-14-05431-g003.jpg
figlink: /pmc/articles/PMC9655342/figure/cancers-14-05431-f003/
number: F3
caption: Overview of cell signaling pathway and targets of novel therapy. Created
  with BioRender.com (accessed on 18 October 2022).
papertitle: Targeted Therapies in Advanced and Metastatic Urothelial Carcinoma.
reftext: Andrew B. Katims, et al. Cancers (Basel). 2022 Nov;14(21):5431.
year: '2022'
doi: 10.3390/cancers14215431
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI
keywords: metastatic urothelial carcinoma | molecular targeted therapy | tumor biomarkers
  | antineoplastic therapy | monoclonal antibodies | antibody-drug conjugates | immunotherapy
  | next-generation sequencing
automl_pathway: 0.9240564
figid_alias: PMC9655342__F3
figtype: Figure
redirect_from: /figures/PMC9655342__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9655342__cancers-14-05431-g003.html
  '@type': Dataset
  description: Overview of cell signaling pathway and targets of novel therapy. Created
    with BioRender.com (accessed on 18 October 2022).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - KRAS
  - HRAS
  - NRAS
  - ERBB3
  - FGFR1
  - FGFR2
  - FGFR4
  - ERBB4
  - FGFR3
  - ERBB2
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3CG
  - PIK3R3
  - PIK3R4
  - PIK3R5
  - PIK3R6
  - PIK3R1
  - PIK3R2
  - XYLT2
  - SOS1
  - SOS2
  - GRB2
  - ZHX2
  - ARAF
  - BRAF
  - RAF1
  - MAP2K7
  - MAP2K1
  - MAP2K2
  - MTG1
  - RHEB
  - RHEBP1
  - AKT1
  - AKT2
  - AKT3
  - TSC1
  - CCL26
  - TSC2
  - MTOR
  - RPTOR
  - NFKB1
  - NECTIN4
  - PAK1
  - PKN1
  - XIAP
  - TP53
  - TP63
  - TP73
  - TACSTD2
  - MDM2
  - rab1ab
  - erbb3a
  - erbb3b
  - fgfr1a
  - fgfr2
  - fgfr4
  - erbb4a
  - fgfr3
  - her2
  - grb2b
  - rheb
  - rhebl1
  - tsc1b
  - tsc2
  - nectin4a
  - nectin4b
  - pak1
  - xiap
  - tp53
  - mdm2
  - Tucatinib Afatinib
  - GDP
  - Erdafitinib
  - Rogaratinib
  - Everolimus
  - XIAP
---
